Hot Products
Hot products from BioCrick which is a professional high-purity natural products manufacturer are well known to scientists around the world because of their high purity and stability. Each product is a chemical compound or substance produced by a living organism—that is, found in nature. In the broadest sense, natural products include any substance produced by life.Natural products remain the best sources of drugs and drug leads, and this remains true today despite the fact that many pharmaceutical companies have deemphasized natural products research in favor of HTP screening of combinatorial libraries during the past 2 decades. From 1940s to date, 131 (74.8%) out of 175 small molecule anticancer drugs are natural product-based/inspired, with 85 (48.6%) being either natural products or derived therefrom. From 1981 to date, 79 (80%) out of 99 small molecule anticancer drugs are natural product-based/inspired, with 53 (53%) being either natural products or derived therefrom. Among the 20 approved small molecule New Chemical Entities (NCEs) in 2010, a half of them are natural products.
Hot products from the professional high-purity natural products manufacturer
| Cat.No. | Product Name |
|---|---|
| BCN3115 | Delphinidin-3-O-rutinoside chloride |
| 1. Delphinidin-3-O-rutinoside chloride has antioxidant activity. | |
| BCN1522 | Delphinidin-3,5-O-diglucoside chloride |
| 1. Delphinidin-3,5-O-diglucoside chloride has antioxidant activity. | |
| BCN3116 | Cyanidin-3,5-O-diglucoside chloride |
| 1. Cyanidin-3,5-O-diglucoside chloride has antioxidant activity. 2. Cyanidin-3,5-O-diglucoside chloride is highly water-soluble and is easily degraded by hydrolysis and /or hydrogenation at temperatures >40°C. | |
| BCN3118 | Dihydrocucurbitacin B |
| Dihydrocucurbitacin B has anti-cancer activity, it reduces cell proliferation due to a decrease in the expression of cyclins, mainly cyclin-B1 and disruption of the actin cytoskeleton, arresting B16F10 cells in G2/M phase. Dihydrocucurbitacin B modifies the evolution of the clinical symptoms, reduces the swelling and bone and tissue damage along with the development of the disease, modifies the cell infiltration and the expression of both nitric oxide synthase-2 and cyclooxygenase-2. | |
| BCN3119 | Cucurbitacin B 2-O-beta-D-glucoside |
| 1. Cucurbitacin B 2-o-β-D-glucoside has anticancer activity. | |
| BCN3120 | Neoquassine |
| 1. Quassin, neoquassin and picrasinoside B are insecticide quassinoids. | |
| BCN3123 | Tanshindiol A |
| 1. Tanshindiol A is potential xanthine oxidase. 2. Tanshindiol A has activity against cancer. 3. Tanshindiol A has activity against cardiovascular diseases. | |
| BCN3124 | Tanshindiol B |
| 1. Tanshindiol B is potential xanthine oxidase inhibitors. | |
